Invitrolize
PrivateLast Round
Seed
May 14, 2025
Total Funding Raised
$1.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Invitrolize is a biotechnology company that provides advanced 3D in vitro models of the human alveolar barrier to identify respiratory sensitizers and irritants for the pharmaceutical, cosmetic, chemical, and consumer goods industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Compliance, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invitrolize Comparables
Compare Invitrolize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoSearch | 94% | |
| XCellR8 | 88% | |
| SenzaGen AB | 80% |
Invitrolize Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 14, 2025 | ||||
| Accelerator | Oct 19, 2023 |
Invitrolize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expon Capital | Seed |
| Luxembourg's Ministry of the Economy | Accelerator |
| Fit 4 Start | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 665% MoM, from 191 to 1.5K.
- May 20, 2026
Monthly visitors increased 79% MoM.
Invitrolize Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Invitrolize's valuation, stock price, and market status.
Is Invitrolize a public or private company?
Invitrolize is a private company.
What is the current stock price of Invitrolize?
Invitrolize is a private company, so its shares have no public market price. Caplight tracks Invitrolize's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Invitrolize worth (valuation)?
Valuation information for Invitrolize is not publicly available.
Can I buy Invitrolize stock?
Invitrolize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Invitrolize's last funding round?
Invitrolize's most recent funding round was Seed on May 14, 2025.
Who are the main investors in Invitrolize?
Key investors in Invitrolize include Expon Capital.
Will Invitrolize IPO soon?
No public IPO plans have been announced for Invitrolize.
How can I track Invitrolize secondary market activity?
Caplight tracks bids, offers, and trades in Invitrolize's shares on secondary markets.